Chan Ka Kit has been appointed Chief Financial Officer of Lijun International Pharmaceutical (Holding) Co., Ltd. He replaces Chow Hing Yeung.
Chan is a member of the Hong Kong Institute of Certified Public Accountants. Chan obtained a Bachelor’s degree of Art in Accountancy from the City University of Hong Kong. He has more than 13 years of experience in areas of accounting and taxation.